Concepedia

Herbert G. Bull

HG

36

Publications

5.7K

Citations

27

H-Index

1971

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Johns Hopkins Medicine

Johns Hopkins University

Cornell University

Herbert G. Bull is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and pharmacology.

Top concepts

Publications per year

1971–2013

36

Publications

36

A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

Nancy A. Thornberry, Herbert G. Bull, Jimmy Calaycay et al. · Nature · 1992 · 2.6K citations

, , +6

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

Margarita García‐Calvo, JeanMarie Lisnock, Herbert G. Bull et al. · Proceedings of the National Academy of Sciences · 2005 · 759 citations · Full text

, , +9

Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.

Margaret A. Cascieri, Herbert G. Bull, Richard A. Mumford et al. · Molecular Pharmacology · 1984 · 169 citations

Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity

Erika Darrah, Jon T. Giles, Michelle Ols et al. · Science Translational Medicine · 2013 · 161 citations · Full text

UDP-N-acetylglucosamine acyltransferase of Escherichia coli. The first step of endotoxin biosynthesis is thermodynamically unfavorable.

Matt S. Anderson, Herbert G. Bull, Susan Galloway et al. · Journal of Biological Chemistry · 1993 · 157 citations · Full text

Rows per page

1–5 of 36